Fig. 4: Baseline characteristics and CONSORT flow diagram for phase 1 clinical trial. | Nature Medicine

Fig. 4: Baseline characteristics and CONSORT flow diagram for phase 1 clinical trial.

From: An oral, liver-restricted LXR inverse agonist for dyslipidemia: preclinical development and phase 1 trial

Fig. 4: Baseline characteristics and CONSORT flow diagram for phase 1 clinical trial.The alternative text for this image may have been generated using AI.

a, Flow diagram for the CONSORT of the TLC-2716 phase 1 clinical trial. b,c, Baseline characterization of healthy participants enrolled in SAD and MAD cohorts in the phase 1 trial. Data are shown as median (minimum, maximum) or n (%).

Back to article page